These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 5995081)

  • 1. [In vitro fibrinolysis of the buffer coat coagulum].
    Harms D; Schmalisch N
    Frankf Z Pathol; 1966; 75(2):148-57. PubMed ID: 5995081
    [No Abstract]   [Full Text] [Related]  

  • 2. Clot lysis in a perfusion system.
    Bouvier CA; Gruendlinger J; Berthoud S
    Thromb Diath Haemorrh; 1966 Jan; 15(1):205-19. PubMed ID: 5919801
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
    [No Abstract]   [Full Text] [Related]  

  • 5. [Post-mortem fibrinolysis in man].
    Harms D
    Veroff Morphol Pathol; 1971; 87():1-74. PubMed ID: 5144656
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).
    Godal HC; Theodor I
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:199+. PubMed ID: 5295419
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current state of anticoagulant and fibrinolytic therapy].
    Hladovec J
    Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activation and inhibition of buffy crust fibrinolysis in vitro].
    Harms D
    Gegenbaurs Morphol Jahrb; 1968; 111(3):488-92. PubMed ID: 4232858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 10. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electron microscope studies of thrombocytes of rabbits before and after administration of epsilon-aminocaproic acid].
    Beznosikova VK; Chaplygina ZA; Beznosikov BO
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):32-7. PubMed ID: 5736821
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation and fibrinolytic system in patients with chronic occlusive peripheral artery disease treated with streptokinase].
    Zola-Sleczek E
    Kardiol Pol; 1973; 16(4):317-22. PubMed ID: 4756966
    [No Abstract]   [Full Text] [Related]  

  • 13. The sensitivity of rabbit plasminogen to streptokinase in circulating blood.
    Janda R
    Folia Histochem Cytochem (Krakow); 1973; 11(3):235-43. PubMed ID: 4778383
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of recombinant human erythropoietin therapy on blood coagulation and fibrinolysis system.
    Kobayashi T; Makuuchi H; Takahashi K; Furuse A; Shibata Y; Tsuno H; Kotsuka Y; Kubota H; Imanaka K; Tsukada T; Nakashima M
    Ann Thorac Cardiovasc Surg; 2001 Oct; 7(5):273-7. PubMed ID: 11743853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Permeability of the blood-aqueous barrier during inhibition of fibrinolysis in blood serum].
    Rudobielski R
    Klin Oczna; 1974 Mar; 44(3):239-42. PubMed ID: 4822124
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental studies on the mechanism of microthrombosis formation].
    Hara H
    Igaku Kenkyu; 1967 Jun; 37(3):333-50. PubMed ID: 4230138
    [No Abstract]   [Full Text] [Related]  

  • 18. [The behavior of plasmatic fibrinogenolytic activity after activation with streptokinase and urokinase in presence of epsilon amino-caproic acid and of the parotid inhibitor of trypsin].
    Ferrauto A; Cristaldi R; Terranova R; Giuffrida G
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1486-7. PubMed ID: 5298373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interrelationship between fibrinolysis and coagulation].
    Berkarda B; Derman U; Akokan G
    Turk Tip Cemiy Mecm; 1967 Mar; 33(3):172-81. PubMed ID: 4166973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F
    Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.